Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Frequency of dyslipidemia in migraineurs in comparison to control group.

Assarzadegan F, Hosseinpanahi SP, Hesami O, Mansouri B, Lima BS.

J Family Med Prim Care. 2019 Mar;8(3):950-954. doi: 10.4103/jfmpc.jfmpc_9_19.

2.

Protective properties of the aqueous extract of saffron (Crocus sativus L.) in ischemic stroke, randomized clinical trial.

Asadollahi M, Nikdokht P, Hatef B, Sadr SS, Sahraei H, Assarzadegan F, Pirzad Jahromi G.

J Ethnopharmacol. 2019 Jun 28;238:111833. doi: 10.1016/j.jep.2019.111833. Epub 2019 Mar 23.

PMID:
30914350
3.

Cognitive Processing Styles and Mindfulness on Pain Intensity Prediction in People with Primary Headache.

Namjoo S, Seirafi M, Assarzadegan F, Borjali A.

Anesth Pain Med. 2018 Nov 19;8(6):e82470. doi: 10.5812/aapm.82470. eCollection 2018 Dec.

4.

Comparison of Pregabalin and Sodium Valproate in Migraine Prophylaxis: A Randomized Double-Blinded Study.

Hesami O, Shams MR, Ayazkhoo L, Assarzadegan F, Safarpour Lima B, Delavar Kasmaei H, Sistanizad M.

Iran J Pharm Res. 2018 Spring;17(2):783-789.

5.

Vitamin B12 Deficiency as a Cause of Neurotrophic Keratopathy.

Nassiri N, Assarzadegan F, Shahriari M, Norouzi H, Kavousnezhad S, Nassiri N, Sheibani K.

Open Ophthalmol J. 2018 Feb 28;12:7-11. doi: 10.2174/1874364101712010007. eCollection 2018.

6.

Tolerability and Efficacy of Memantine as Add on Therapy in Patients with Migraine.

Assarzadegan F, Sistanizad M.

Iran J Pharm Res. 2017 Spring;16(2):791-797.

7.

Acute management of stroke in Iran: Obstacles and solutions.

Shahjouei S, Bavarsad-Shahripour R, Assarzadegan F, Rikhtegar R, Mehrpour M, Zamani B, Tsivgoulis G, Alexandrov A, Alexandrov A, Zand R.

Iran J Neurol. 2017 Apr 4;16(2):62-71.

8.

Efficacy and Safety of MLC601 in the Treatment of Mild Cognitive Impairment: A Pilot, Randomized, Double-Blind, Placebo-Controlled Study.

Pakdaman H, Amini Harandi A, Abbasi M, Delavar Kasmaei H, Ashrafi F, Gharagozli K, Assarzadegan F, Behnam B, Arabahmadi M.

Dement Geriatr Cogn Dis Extra. 2017 May 4;7(1):136-142. doi: 10.1159/000458521. eCollection 2017 Jan-Apr.

9.

Comparing Zonisamide With Sodium Valproate in the Management of Migraine Headaches: Double-Blind Randomized Clinical Trial of Efficacy and Safety.

Assarzadegan F, Tabesh H, Hosseini-Zijoud SM, Beale AD, Shoghli A, Ghafoori Yazdi M, Mansouri B, Hesami O, Beladi Moghadam N, Delavar Kasmaei H.

Iran Red Crescent Med J. 2016 Apr 30;18(9):e23768. doi: 10.5812/ircmj.23768. eCollection 2016 Sep.

10.

Health-related quality of life in patients with relapsing-remitting multiple sclerosis treated with subcutaneous interferon β-1a in Iran.

Pakdaman H, Amini Harandi A, Gharagozli K, Abbasi M, Tabassi A, Ashrafi F, Ghaffarpor M, Sharifi S, Delavar Kasmae H, Assarzadegan F, Arabahmadi M, Behnam B.

Int J Neurosci. 2017 Jun;127(6):501-507. doi: 10.1080/00207454.2016.1198793. Epub 2016 Jul 19. Erratum in: Int J Neurosci. 2017 Jun;127(6):i.

PMID:
27279451
11.

Serum concentration of magnesium as an independent risk factor in migraine attacks: a matched case-control study and review of the literature.

Assarzadegan F, Asgarzadeh S, Hatamabadi HR, Shahrami A, Tabatabaey A, Asgarzadeh M.

Int Clin Psychopharmacol. 2016 Sep;31(5):287-92. doi: 10.1097/YIC.0000000000000130. Review.

PMID:
27140442
12.

Evaluation of Ocular Side Effects in the Patients on Topiramate Therapy for Control of Migrainous Headache.

Hesami O, Hosseini SS, Kazemi N, Hosseini-Zijoud SM, Moghaddam NB, Assarzadegan F, Mokhtari S, Fakhraee S.

J Clin Diagn Res. 2016 Mar;10(3):NC01-4. doi: 10.7860/JCDR/2016/16263.7339. Epub 2016 Mar 1.

13.

The buffering effect of family functioning on the psychological consequences of headache.

Mohammadi S, Zandieh S, Dehghani M, Assarzadegan F, Sanderman R, Hagedoorn M.

Psychol Health Med. 2017 Feb;22(2):237-243. Epub 2016 Feb 17.

PMID:
26885696
14.

c.376G>A mutation in WFS1 gene causes Wolfram syndrome without deafness.

Safarpour Lima B, Ghaedi H, Daftarian N, Ahmadieh H, Jamshidi J, Khorrami M, Noroozi R, Sohrabifar N, Assarzadegan F, Hesami O, Taghavi S, Ahmadifard A, Atakhorrami M, Rahimi-Aliabadi S, Shahmohammadibeni N, Alehabib E, Andarva M, Darvish H, Emamalizadeh B.

Eur J Med Genet. 2016 Feb;59(2):65-9. doi: 10.1016/j.ejmg.2016.01.001. Epub 2016 Jan 7.

PMID:
26773575
15.

Relation of Stroke Risk Factors with Specific Stroke Subtypes and Territories.

Assarzadegan F, Tabesh H, Shoghli A, Ghafoori Yazdi M, Tabesh H, Daneshpajooh P, Yaseri M.

Iran J Public Health. 2015 Oct;44(10):1387-94.

16.

Measuring Serum Level of Ionized Magnesium in Patients with Migraine.

Assarzadegan F, Asadollahi M, Derakhshanfar H, Kashefizadeh A, Aryani O, Khorshidi M.

Iran J Child Neurol. 2015 Summer;9(3):13-6.

17.

The Role of Antiepileptic Treatment in the Recurrence Rate of Seizures After First Attack: A Randomized Clinical Trial.

Assarzadegan F, Tabesh H, Hesami O, Derakhshanfar H, Beladi Moghadam N, Shoghli A, Beale AD, Hosseini-Zijoud SM.

Iran J Child Neurol. 2015 Spring;9(2):46-52.

18.

The Efficacy of Gabapentin in Patients with Central Post-stroke Pain.

Hesami O, Gharagozli K, Beladimoghadam N, Assarzadegan F, Mansouri B, Sistanizad M.

Iran J Pharm Res. 2015 Winter;14(Suppl):95-101.

19.

Intracranial hypertension and cerebellar symptoms due to Lhermitte-Duclos disease.

Assarzadegan F, Gharib A, Behbahani S, Ebrahimi-Abyaneh M.

Iran J Neurol. 2015 Apr 4;14(2):113-5. No abstract available.

20.

Relationship between intracerebral hemorrhage and diabetes mellitus: a case-control study.

Hesami O, Kasmaei HD, Matini F, Assarzadegan F, Mansouri B, Jabbehdari S.

J Clin Diagn Res. 2015 Apr;9(4):OC08-10. doi: 10.7860/JCDR/2015/12226.3741. Epub 2015 Apr 1.

21.

Comparison of therapeutic effects of magnesium sulfate vs. dexamethasone/metoclopramide on alleviating acute migraine headache.

Shahrami A, Assarzadegan F, Hatamabadi HR, Asgarzadeh M, Sarehbandi B, Asgarzadeh S.

J Emerg Med. 2015 Jan;48(1):69-76. doi: 10.1016/j.jemermed.2014.06.055. Epub 2014 Sep 30.

PMID:
25278139
22.

Risk factors for increased multiple sclerosis susceptibility in the Iranian population.

Mansouri B, Asadollahi S, Heidari K, Fakhri M, Assarzadegan F, Nazari M, Divani A.

J Clin Neurosci. 2014 Dec;21(12):2207-11. doi: 10.1016/j.jocn.2014.04.020. Epub 2014 Jul 28.

PMID:
25082407
23.

Secondary headaches attributed to arterial hypertension.

Assarzadegan F, Asadollahi M, Hesami O, Aryani O, Mansouri B, Beladi Moghadam N.

Iran J Neurol. 2013;12(3):106-10. Review.

24.

Superficial siderosis: A rare case of ataxia and otoneurological manifestations.

Assarzadegan F, Ehsanpour E, Hosseini B, Beladi-Moghadam N, Mansouri B, Hesami O.

Iran J Neurol. 2013;12(2):69-71.

25.

New pathogenic variations of mitochondrial DNA in Alzheimer disease!!

Nia SS, Azadfar P, Akbari L, Assarzadegan F, Kamalidehghan B, Maroof HR, Houshmand M.

J Res Med Sci. 2013 Mar;18(3):269. No abstract available.

26.

Mortality and functional disability after spontaneous intracranial hemorrhage: the predictive impact of overall admission factors.

Mansouri B, Heidari K, Asadollahi S, Nazari M, Assarzadegan F, Amini A.

Neurol Sci. 2013 Nov;34(11):1933-9. doi: 10.1007/s10072-013-1410-0. Epub 2013 Mar 30.

PMID:
23543380
27.

Wernicke's encephalopathy in a non-alcoholic Patient: Difficulties of early diagnosis and treatment.

Hesami O, Beladimoghaddam N, Assarzadegan F, Kazemi N.

Iran J Neurol. 2012;11(4):159-61. No abstract available.

Supplemental Content

Loading ...
Support Center